The impact of the International Conference on Harmonization (ICH) on pharmacoepidemiology and pharmacovigilance

被引：0

作者：

Goldsmith, DI ^{[1
]}

机构：

[1] Sanofi Pharmaceut, New York, NY 10016 USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 1998年 / 7卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：289 / 291

页数：3

共 50 条

[21] International Conference on Harmonization-Keeping International Drug Development in Harmony?
Craig McCarthy
Drug information journal : DIJ / Drug Information Association, 2001, 35 : 369 - 376
[22] International Conference on Harmonization Impurity Guidelines—The Industry Perspective
Guy Rousseau
Peter Jeffs
Drug information journal : DIJ / Drug Information Association, 2000, 34 (3): : 903 - 907
[23] Basis for sample size in International Conference on Harmonization Guidances
Lubiniecki, A
Vaccine Cell Substrates 2004, 2006, 123 : 201 - 205
[24] International conference on harmonization - Good clinical practices update
Barton, BL
DRUG INFORMATION JOURNAL, 1998, 32 (04): : 1143 - 1147
[25] Achieving global consensus through the International Conference on Harmonization
Kaufman, Zena G.
Beno, Diane
BIOPHARM INTERNATIONAL, 2006, : 24 - +
[26] International Conference on Harmonization Impurity Guidelines - The industry perspective
Rousseau, G
Jeffs, P
DRUG INFORMATION JOURNAL, 2000, 34 (03): : 903 - 907
[27] The role of pharmacoepidemiology in pharmacovigilance:: A conference at the 6th ESOP Meeting, Budapest, 28 September 1998
Abenhaim, L
Moore, N
Bégaud, B
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 1999, 8 : S1 - S7
[28] A European network of centres for pharmacovigilance and pharmacoepidemiology (ENCePP)
Wathion, Noel A.
Blackburn, Stella
Kurz, Xavier
Persson, Ingemar R.
Moride, Yola
Sturkenboom, Miriam C. J. M.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S26 - S26
[29] Globalizing quality in clinical trials: a nursing perspective on the main changes in the International conference on Harmonization Good Clinical Practice (ICH-GCP) guideline
de Boer, M
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S26 - S26
[30] IMPLICATIONS OF RECOMMENDATIONS FROM THE INTERNATIONAL-CONFERENCE ON HARMONIZATION (ICH) FOR THE SAFETY EVALUATION OF NEW MEDICINES INVOLVING ANIMAL STUDIES FOR THE PHARMACEUTICAL-INDUSTRY
SCALES, MDC
ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS, 1992, 11 (01): : 5 - 12

← 1 2 3 4 5 →